Details for 2010010795

Up to date per 02.04.2026

Actions

Title / Product Name

Antikörpermoleküle mit Spezifizität für menschlichen Tumornekrosefaktor-alpha, und deren Verwendung

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2010010795

EP Publication Number

2308975

E-Number

819096

Language

PCT Number

Publication Date

13.04.2011 A

10.08.2016 B1

Registration Date

10.08.2016

AT Publication Date

15.08.2016

Application Date

05.06.2001

Registration Number

Priorities

06.06.2000

0013810

IPC

C12N 15/13 20060101AFI20110222BHEP

Maximum Duration of Protection

05.06.2021

Owner

UCB Pharma, S.A.Allée de La Recherche 60 1070 BrusselsBE

Representative

SONN & PARTNER PATENTANWÄLTE WIEN

Inventor

Athwal, Diljeet Singhc/o Intellectual Property Dpt. UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Brown, Derek Thomasc/o Intellectual Property Dpt. UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Weir, Andrew Neil Charlesc/o Intellectual Property Dpt. UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Popplewell, Andrew Georgec/o Intellectual Property Dpt. UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Chapman, Andrew Paulc/o Intellectual Property Dpt. UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

King, David Johnc/o Intellectual Property Dpt. UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB